SECsense Logo

ORIC Pharmaceuticals, Inc. 8-K Report: Key Insights from February 18, 2025 Filing

$ORIC
Form 8-K
Filed on: 2025-02-18
Source
ORIC Pharmaceuticals, Inc. 8-K Report: Key Insights from February 18, 2025 Filing

Here are the key insights extracted from the provided financial report section:

  1. Entity Information:
  • Company Name: ORIC Pharmaceuticals, Inc.
  • CIK (Central Index Key): 0001796280
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-39269
  • EIN (Employer Identification Number): 47-1787157
  • Address: 240 E. Grand Ave, 2nd Floor, South San Francisco, CA 94080
  • Contact Number: (650) 388-5600
  1. Filing Details:
  • Form Type: 8-K (a report of unscheduled material events or corporate changes)
  • Filing Date: February 18, 2025
  1. Stock Information:
  • Common Stock Par Value: $0.0001 per share
  • Stock Exchange: NASDAQ
  • Ticker Symbol: ORIC
  1. Reporting Period:
  • Report Date Range: The report is for a single day, February 18, 2025.
  1. Additional Information:
  • The filing is associated with XBRL (eXtensible Business Reporting Language), indicating it is structured for digital reporting and analysis.

This information highlights the basic details regarding ORIC Pharmaceuticals, Inc., the nature of the filing, and relevant identifiers, which are crucial for investors and analysts tracking the company's performance and regulatory compliance.